Large Study Eases Fears Over Zantac-Cancer Link
(MedPage Today) -- People who took ranitidine (Zantac) for at least a month were no more likely to develop cancer than people who used other histamine-2 receptor antagonists (H2RAs), according to a retrospective observational study with a multinational... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 19, 2023 Category: American Health Source Type: news
News at a glance: Logging ’s effects, endangered abalone, and a contract for UC postdocs
CONSERVATION
Life can thrive in a partially logged forest, study finds
Forest
plants and animals can thrive in selectively logged areas
, calling into question their designation as degraded ecosystems, a study in Malaysia has found. An international team of researchers studied differences among an intact old forest, partly logged forest areas, and sites cleared for oil palm plantations, all of them in Sabah state on northern Borneo. The scientists used data—gathered over 12 years by the Stability of Altered Forest Ecosystems project, one of the world’s largest ecological studies—abou...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
No plans to reintroduce Zinetac in India: GSK
British drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, despite the US court last week ruling that there is no sound scientific evidence to back the claims that the drug increases the risk of cancer. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2022 Category: Pharmaceuticals Source Type: news
Heartburn medicine taken by millions has been linked to higher risk of 7 cancers
From oesophageal to colorectal cancer, research has linked ranitidine to the deadly condition. (Source: Daily Express - Health)
Source: Daily Express - Health - October 26, 2022 Category: Consumer Health News Source Type: news
Pharma Industry staring at 30-40 bps hit on updated NLEM
Manchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins as they are mostly procured by the government through tenders. There are potential beneficiaries also with the new NLEM. The removal of antacid molecule ranitidine which has more than Rs 600 crore annual sales is expected to benefit JB Pharma and Cadila Pharmaceuticals. (Source: The Economic Times)
Source: The Economic Times - September 14, 2022 Category: Consumer Health News Source Type: news
New Clues to Men's Cancer Risk; Exercise and Chemo; GSK Pushes Back on Ranitidine
(MedPage Today) -- New clues to why men develop cancer more often than women. (U.S. News & World Report)
Dutch oncologists and surgeons performed the first mandibular implant using a titanium mandible made from 3D images of a patient with... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 12, 2022 Category: Hematology Source Type: news
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens. (Source: NYT Health)
Source: NYT Health - March 23, 2022 Category: Consumer Health News Authors: Christina Jewett Tags: Drugs (Pharmaceuticals) Recalls and Bans of Products Cancer Food and Drug Administration Pfizer Inc your-feed-healthcare Accuretic nitrosamine valsartan Valisure ranitidine N-nitrosodimethylamine ndma metformin benzene Source Type: news
ranitidine
Title: ranitidineCategory: MedicationsCreated: 5/12/2021 12:00:00 AMLast Editorial Review: 9/28/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 28, 2021 Category: Drugs & Pharmacology Source Type: news
Chronic Use of Ranitidine and Gastrointestinal Malignancies Chronic Use of Ranitidine and Gastrointestinal Malignancies
Unacceptable levels of NDMA in ranitidine caused it to be removed it from the market. Do patients who took ranitidine have a higher risk of GI cancer compared with those on other anti-reflux drugs?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 8, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Ensuring the Rigor of Regulatory Science: CDER Conducts Laboratory and Clinical Studies to Investigate Reports of NDMA Production from Ingested Ranitidine Products
Ranitidine, which blocks histamine-induced acid secretion in the stomach, was approved in 1983. It became widely used over the ensuing decades as a prescription and over-the-counter product. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 2, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
NPPA approves price rise of 50 per cent for carbamazepine, ranitidine, ibuprofen
NPPA, in its meeting on June 28, deliberated upon the case of upward price revision of the formulations of these drugs under Para 19 of DPCO 2013 and noted that the scheduled formulations being considered for upward price revision are low-priced drugs and have been under repeated price controls, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 2, 2021 Category: Pharmaceuticals Source Type: news
Heartburn Drug and Cancer: Does the Link Hold? Heartburn Drug and Cancer: Does the Link Hold?
Could this new wrinkle mean a return of ranitidine, a best-selling drug since the FDA approved it as Zantac in 1983?WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Widely Covered Paper on Ranitidine-Cancer Link Retracted Widely Covered Paper on Ranitidine-Cancer Link Retracted
The authors concluded that their widely touted finding appears to have resulted from a hiccup in the way they conducted their testing.Retraction Watch (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 15, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
FDA Updates and Press Announcements on NDMA in Ranitidine (Zantac)
FDA alerts health care professionals and patients to voluntary recall of ranitidine medicines (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Popular Heartburn Drugs Linked to Heightened COVID-19 Risk
A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus.
In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
